用伊普塔科潘成功管理C3球膜病变的移植后复发:一个案例报告
Dario Troise1,2, Barbara Infante1, Silvia Mercuri1
1Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.cK.A), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
International journal of molecular sciences
|June 13, 2025
概括
移植后的C3球囊病变 (C3G) 复发可能很难治疗. 补充剂抑制剂伊普塔科潘 (Iptacopan) 在移植患者中显示显著的临床和组织学改善,患者有C3G复发.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- C3球囊病 (C3G) 是一种罕见的病,由替代补充路径的失调引起.
- 目前对C3G的治疗方法,特别是移植后的复发,缺乏确定的指导方针,并显示出有限的疗效.
- 针对补充系统是C3G的一个有前途的治疗策略.
更多相关视频
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Angle Closure Glaucoma: Treatment
454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454


